These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7516920)

  • 1. Quantization of CD34+ peripheral blood hematopoietic progenitors for autografting in cancer patients.
    Di Nicola M; Siena S; Bregni M; Peccatori F; Magni M; Ravagnani F; Zorzino L; Bonadonna G; Gianni AM
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():80-2. PubMed ID: 7516920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients.
    Siena S; Bregni M; Brando B; Belli N; Ravagnani F; Gandola L; Stern AC; Lansdorp PM; Bonadonna G; Gianni AM
    Blood; 1991 Jan; 77(2):400-9. PubMed ID: 1702334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patients.
    Ravagnani F; Siena S; Bregni M; Brando B; Belli N; Lansdorp PM; Notti P; Pellegris G; Gianni AM
    Haematologica; 1991 Mar; 76 Suppl 1():46-9. PubMed ID: 1713874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological evaluation of harvested stem cells obtained by leukapheresis after chemotherapy.
    Teixeira G; Lenormand B; Jean P; Fardoun D; Sumereau-Dassin E; Bastit D; Tilly H; Piguet H; Monconduit M; Vannier JP
    Am J Hematol; 1992 Mar; 39(3):172-5. PubMed ID: 1372150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
    Hohaus S; Goldschmidt H; Ehrhardt R; Haas R
    Exp Hematol; 1993 Apr; 21(4):508-14. PubMed ID: 7681782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of chemotherapy mobilized peripheral blood progenitor cells for use in autologous stem cell transplantation.
    Bender JG; Williams SF; Myers S; Nottleman D; Lee WJ; Unverzagt KL; Walker D; To LB; Van Epps DE
    Bone Marrow Transplant; 1992 Sep; 10(3):281-5. PubMed ID: 1384900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood cell harvests yield primitive multilineage progenitor cells in the CD34+/33- fraction.
    Croockewit A; Raymakers RA; Trilsbeek C; Dolstra H; Pennings A; De Witte TJ; Haanen C
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():83-8. PubMed ID: 7516921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparameter flow-cytometrical quantitation of circulating CD34(+)-cells: correlation to the quantitation of circulating haemopoietic progenitor cells by in vitro colony-assay.
    Serke S; Säuberlich S; Huhn D
    Br J Haematol; 1991 Apr; 77(4):453-9. PubMed ID: 1709040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
    Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
    Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of CD34+ cells mobilized to the peripheral blood during the recovery from cyclophosphamide chemotherapy.
    Bender JG; Unverzagt KL; Walker DE; Lee W; Lum L; Van Epps DE; Williams SF; To LB
    Prog Clin Biol Res; 1992; 377():575-82. PubMed ID: 1279727
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.
    Passos-Coelho JL; Braine HG; Davis JM; Huelskamp AM; Schepers KG; Ohly K; Clarke B; Wright SK; Noga SJ; Davidson NE
    J Clin Oncol; 1995 Mar; 13(3):705-14. PubMed ID: 7533827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primitive multilineage progenitor cells predominate in peripheral blood early after mobilization with high-dose cyclophosphamide and GM-CSF or G-CSF.
    Croockewit S; Raymakers R; Trilsbeek C; Dolstra H; Pennings A; de Witte T
    Leukemia; 1994 Dec; 8(12):2194-9. PubMed ID: 7528861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation.
    Kiss JE; Rybka WB; Winkelstein A; deMagalhaes-Silverman M; Lister J; D'Andrea P; Ball ED
    Bone Marrow Transplant; 1997 Feb; 19(4):303-10. PubMed ID: 9051238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of CD34+ cells mobilized into the peripheral blood predicts the yield of the leukapheresis product and can replace progenitor assays.
    D'Hondt L; André M; Guillaume T; Feyens AM; Humblet Y; Doyen C; Bosly A; Dromelet A; Chatelain B; Symann M
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):21-6. PubMed ID: 9287240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD34 analysis in peripheral blood correlates with colony forming capacity--an update.
    Fritsch G; Emminger W; Buchinger P; Printz D; Gadner H
    Prog Clin Biol Res; 1992; 377():531-6. PubMed ID: 1279721
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytokine-mobilized peripheral blood CD34+Thy-1+Lin- human hematopoietic stem cells as target cells for transplantation-based gene therapy.
    Chen BP; Fraser C; Reading C; Murray L; Uchida N; Galy A; Sasaki D; Tricot G; Jagannath S; Barlogie B
    Leukemia; 1995 Oct; 9 Suppl 1():S17-25. PubMed ID: 7475307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support.
    Papadopoulos KP; Ayello J; Tugulea S; Heitjan DF; Williams C; Reiss RF; Vahdat LT; Suciu-Foca N; Antman KH; Hesdorffer CS
    J Hematother; 1997 Feb; 6(1):61-8. PubMed ID: 9112219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.